RBBP9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.70969904900176E-11 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.31479999904749E-08 |
Normal-vs-Stage2 |
6.761100E-04 |
Normal-vs-Stage3 |
3.48480000411655E-08 |
Normal-vs-Stage4 |
1.80060000243287E-08 |
Stage1-vs-Stage2 |
4.675000E-01 |
Stage1-vs-Stage3 |
3.311800E-02 |
Stage1-vs-Stage4 |
2.102500E-02 |
Stage2-vs-Stage3 |
4.489000E-01 |
Stage2-vs-Stage4 |
4.484800E-01 |
Stage3-vs-Stage4 |
9.343000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
7.20560278111293E-11 |
Normal-vs-AfricanAmerican |
1.52664999999441E-05 |
Normal-vs-Asian |
8.011700E-02 |
Caucasian-vs-AfricanAmerican |
3.503600E-01 |
Caucasian-vs-Asian |
5.797200E-01 |
AfricanAmerican-vs-Asian |
8.639600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.23079998917797E-10 |
Normal-vs-Female |
1.50460000014618E-09 |
Male-vs-Female |
9.685200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.94472999999196E-05 |
Normal-vs-Age(41-60Yrs) |
5.64330000507596E-08 |
Normal-vs-Age(61-80Yrs) |
9.71069891164689E-11 |
Normal-vs-Age(81-100Yrs) |
2.999600E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.214500E-02 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.319800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.934030E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.482600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.912000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.204200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.432800E-01 |
Normal-vs-Grade 2 |
9.11089999999781E-07 |
Normal-vs-Grade 3 |
7.23179960360198E-10 |
Normal-vs-Grade 4 |
1.96054283918556E-12 |
Grade 1-vs-Grade 2 |
1.326610E-01 |
Grade 1-vs-Grade 3 |
1.712960E-01 |
Grade 1-vs-Grade 4 |
3.568200E-02 |
Grade 2-vs-Grade 3 |
2.722000E-01 |
Grade 2-vs-Grade 4 |
1.839330E-04 |
Grade 3-vs-Grade 4 |
2.757000E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
3.407300E-04 |
Normal-vs-ccB subtype |
1.65969460397264E-11 |
ccA subtype-vs-ccB subtype |
3.64080000000433E-05 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.98870000467366E-08 |
Normal-vs-N1 |
2.851900E-02 |
N0-vs-N1 |
4.393400E-01 |
|
|